This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Information about Myotonic Disorders: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Most recent studies have shown that Myotonic Disorders shares some biological mechanisms with atrophy, channelopathies, dystrophia-myotonica-2, dystrophy, hyperkalemic-periodic-paralysis, multisystem-disorder, muscle-weakness, muscular-dystrophy, myalgia, myopathy, myotonia-congenita, myotonic-dystrophy, myotonic-myopathy-proximal, neuromuscular-diseases, pain, paramyotonia-congenita-(disorder), periodic-paralysis-(finding), trinucleotide-repeat-expansion, weakness.
Among the many pathways, these few ones have gauged particular interests from scientists studying Myotonic Disorders, and have been seen in publications frequently: Aging, Bone Maturation, Cardiac Conduction, Cell Differentiation, Immune Response, Innate Immune Response, Innervation, Localization, Membrane Depolarization, Muscle Atrophy, Muscle Cell Differentiation, Muscle Contraction, Pathogenesis, Phagocytosis, Reflex, Regeneration, Response To Cold, Rna Splicing, Senescence, Translation
Quite a number of genes have been found to play important roles in Myotonic Disorders, such as CACNA1S, CCT3, CELF1, CHKA, CLCN1, CNBP, CST7, DBNL, DMD, DMPK, GRIP1, INS, INSR, KCNE3, MAPT, MBNL1, SCN4A, TG, ZNF273. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.